Anthony S Don1, Hugh Rosen. 1. Cancer Research Centre, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.
Abstract
The lipid second messenger sphingosine 1-phosphate (S1P) is a critical mediator of cellular proliferation and survival signals, and is essential for vasculogenesis and neurogenesis. S1P formation is catalysed by sphingosine kinases 1 and 2 (Sphk1 and Sphk2). We have found that the endogenous glycolipid sulfatide (3-O-sulfogalactosylceramide) binds to and inhibits the activity of Sphk2 and the closely related ceramide kinase (Cerk), but not Sphk1. Using sulfatide as a probe, we mapped the lipid binding domain to the N-terminus of Sphk2 (residues 1-175), a region of sequence that is absent in Sphk1, but aligns with a pleckstrin homology domain in Cerk. Accordingly, Sphk2 bound to phosphatidylinositol monophosphates but not to abundant cellular phospholipids. Deleting the N-terminal domain reduced Sphk2 membrane localisation in cells. We have therefore identified a lipid binding domain in Sphk2 that is important for the enzyme's sub-cellular localisation.
The pan class="Chemical">lipid second messenger n>n class="Chemical">sphingosine 1-phosphate (S1P) is a critical mediator of cellular proliferation and survival signals, and is essential for vasculogenesis and neurogenesis. S1P formation is catalysed by sphingosine kinases 1 and 2 (Sphk1 and Sphk2). We have found that the endogenous glycolipid sulfatide (3-O-sulfogalactosylceramide) binds to and inhibits the activity of Sphk2 and the closely related ceramide kinase (Cerk), but not Sphk1. Using sulfatide as a probe, we mapped the lipid binding domain to the N-terminus of Sphk2 (residues 1-175), a region of sequence that is absent in Sphk1, but aligns with a pleckstrin homology domain in Cerk. Accordingly, Sphk2 bound to phosphatidylinositol monophosphates but not to abundant cellular phospholipids. Deleting the N-terminal domain reduced Sphk2 membrane localisation in cells. We have therefore identified a lipid binding domain in Sphk2 that is important for the enzyme's sub-cellular localisation.
Authors: Michael Maceyka; Heidi Sankala; Nitai C Hait; Hervé Le Stunff; Hong Liu; Rachelle Toman; Claiborne Collier; Min Zhang; Leslie S Satin; Alfred H Merrill; Sheldon Milstien; Sarah Spiegel Journal: J Biol Chem Date: 2005-08-23 Impact factor: 5.157
Authors: Hugh Rosen; Pedro Gonzalez-Cabrera; David Marsolais; Stuart Cahalan; Anthony S Don; M Germana Sanna Journal: Immunol Rev Date: 2008-06 Impact factor: 12.988
Authors: Michael Merten; Christian Beythien; Kai Gutensohn; Peter Kühnl; Thomas Meinertz; Perumal Thiagarajan Journal: Arterioscler Thromb Vasc Biol Date: 2004-11-04 Impact factor: 8.311
Authors: Kevin J French; Randy S Schrecengost; Brian D Lee; Yan Zhuang; Staci N Smith; Justin L Eberly; Jong K Yun; Charles D Smith Journal: Cancer Res Date: 2003-09-15 Impact factor: 12.701
Authors: Stuart M Pitson; Pu Xia; Tamara M Leclercq; Paul A B Moretti; Julia R Zebol; Helen E Lynn; Binks W Wattenberg; Mathew A Vadas Journal: J Exp Med Date: 2004-12-28 Impact factor: 14.307
Authors: Mohamad M Adada; Daniel Canals; Nara Jeong; Ashwin D Kelkar; Maria Hernandez-Corbacho; Michael J Pulkoski-Gross; Jane C Donaldson; Yusuf A Hannun; Lina M Obeid Journal: FASEB J Date: 2015-07-24 Impact factor: 5.191
Authors: Ying Liu; Yanfeng Chen; Amin Momin; Rebecca Shaner; Elaine Wang; Nathan J Bowen; Lilya V Matyunina; L Deette Walker; John F McDonald; M Cameron Sullards; Alfred H Merrill Journal: Mol Cancer Date: 2010-07-12 Impact factor: 27.401
Authors: Sandra E Dillahunt; Jennifer L Sargent; Ryo Suzuki; Richard L Proia; Alasdair Gilfillan; Juan Rivera; Ana Olivera Journal: J Immunol Date: 2013-01-28 Impact factor: 5.422